investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:

Skin stock segment: trending tickers

ARQT Arcutis Biotherapeutics, Inc. - Common stock 1.41% 1.41% 0 + Skin, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1787306/000178730625000147/0001787306-25-000147-index.htm
8-K - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)
+ My List
FBRX Forte Biosciences, Inc. - Common Stock 7.92% 7.92% 0 + Skin, Medicine, Disease: Infectious, Biopharma

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1419041/000119312526148796/0001193125-26-148796-index.htm
8-K - Forte Biosciences, Inc. (0001419041) (Filer)
+ My List
GALT Galectin Therapeutics Inc. - Common Stock 8.85% 8.85% 0 + Cancer fight, Disease: Liver, Skin, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1133416/000114036126012158/0001140361-26-012158-index.htm
8-K - GALECTIN THERAPEUTICS INC (0001133416) (Filer)
+ My List
HOTH Hoth Therapeutics, Inc. - Common Stock -2.7% -2.7% 0 + Medicine, Biopharma, Skin

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1711786/000121390026044741/0001213900-26-044741-index.htm
8-K - Hoth Therapeutics, Inc. (0001711786) (Filer)
+ My List
SRTS Sensus Healthcare, Inc. - Common Stock 1.13% 1.13% 0 + Skin, Medicine

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1494891/000175392626000435/0001753926-26-000435-index.htm
10-K - Sensus Healthcare, Inc. (0001494891) (Filer)
+ My List
TRDA Entrada Therapeutics, Inc. - Common Stock 5.24% 5.24% 0 + Medicine, Skin

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1689375/000168937526000011/0001689375-26-000011-index.htm
10-K - Entrada Therapeutics, Inc. (0001689375) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.